Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/5/2026

1. LULU
2. ZS
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
(NASDAQ: ACRV) Delayed: 2.13 +0.07 (3.40%)
Previous Close $2.06    52 Week High $ 
Open $2.06    52 Week Low $ 
Day High $2.14    P/E N/A 
Day Low $2.06    EPS $ 
Volume 184,594